Cargando…
Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage
Vascular endothelial growth factor antagonism with angiogenesis inhibitors in cancer patients induces a ‘preeclampsia-like’ syndrome including hypertension, proteinuria and elevated endothelin (ET)-1. Cyclo-oxygenase (COX) inhibition with aspirin is known to prevent the onset of preeclampsia in high...
Autores principales: | Mirabito Colafella, Katrina M., van Dorst, Daan C.H., Neuman, Rugina I., Doorn, Leni van, Neves, Karla Bianca, Montezano, Augusto C., Garrelds, Ingrid M., van Veghel, Richard, de Vries, René, Uijl, Estrellita, Clahsen-van Groningen, Marian C., Baelde, Hans J., van den Meiracker, Anton H., Touyz, Rhian M., Visser, Willy, Danser, A.H. Jan, Versmissen, Jorie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093150/ https://www.ncbi.nlm.nih.gov/pubmed/35441670 http://dx.doi.org/10.1042/CS20220182 |
Ejemplares similares
-
Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?
por: Mirabito Colafella, Katrina M., et al.
Publicado: (2019) -
Blood pressure‐independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes
por: Cruz‐López, Edwyn O., et al.
Publicado: (2022) -
Conventional Vasopressor and Vasopressor‐Sparing Strategies to Counteract the Blood Pressure–Lowering Effect of Small Interfering RNA Targeting Angiotensinogen
por: Uijl, Estrellita, et al.
Publicado: (2022) -
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension
por: van Doorn, Leni, et al.
Publicado: (2022) -
Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor‐Induced Blood Pressure Rise: A Clinical Cohort Study
por: van Dorst, Daan C. H., et al.
Publicado: (2022)